In consultation: Guidance and quality standards

Skip to filters Skip to results

Showing 1 to 2 of 2

Sort by

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter

Guidance and quality standards in consultation
Title	Consultation	Type	Consultation end date
Obecabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia [ID6347]	Draft guidance	Technology appraisal guidance	4 July 2025
Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [ID6212]	Draft guidance	Technology appraisal guidance	3 July 2025

Results per page

10
25
50
All